AGTC Reports Additional Positive Data From Its Phase 1/2 Clinical Trial in Patients With X-Linked Retinitis Pigmentosa
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, reported positive data from its ongoing Phase 1/2 clinical program in patients with X-linked retinitis pigmentosa (XLRP). Visual sensitivity, visual acuity […]
Lacerta Therapeutics Signs Gene Therapy Research Partnership With UCB
UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced a new gene therapy research collaboration with UCB, a global biopharmaceutical company. The research collaboration and licensing agreement with UCB will focus on a central nervous system (CNS) disease with a high unmet need. “At Lacerta, we […]
Lacerta Therapeutics Strengthens Its Position in the AAV Gene Therapy Space With New Leadership
UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company, announced new leadership. Dr. Edgar Rodriguez-Lebron, co-founder, will serve as president and chairman of the Board of Directors. Co-founders and scientific advisors, Drs. Ken Warrington and Coy Heldermon, will round out the additions to the board. The company […]
Department of Defense Awards Ology Bioservices Contract to Manufacture and Test Novel Live Attenuated Tularemia Vaccine Candidate
UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced that the Department of Defense (DOD), through the Joint Science and Technology Office of the Defense Threat Reduction Agency (DTRA), has awarded the company with a contract to manufacture a novel live attenuated […]
BioFlorida Honors Two UF Startups for Their Role in Fighting COVID-19
Molekule receives COVID-19 Innovation Award; Ology Bioservices receives David J. Gury Company of the Year Award COVID-19 Innovation Award The COVID-19 Innovation Award recognizes a Florida company that has made significant advances in the fight against COVID-19. The 2020 COVID-19 Innovation Award was presented to Dr. Yogi Goswami, the world-renowned Director of the Clean Energy Research Center […]
The Academic Engine That Propels Young Companies
Like universities around the world, the University of Florida via UF Innovate helps startup companies get off the ground with the support of a business incubator and leading-edge high-performance computing. Around the world, universities are not just centers for teaching and research, but also engines for product innovation and business incubation. Countless numbers of startup […]
ABEC Supporting Ology Bioservices COVID-19 Therapeutic Manufacturing Programs
ABEC, a leading global provider of integrated solutions and services for biopharmaceutical manufacturing, announced it is delivering process systems to UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), to support their production of critical vaccines and therapeutics for COVID-19. ABEC is providing […]
entrinsic bioscience Secures U.S. Patent Grant for Breakthrough Respiratory Disease Program
UF startup and UF Innovate | Sid Martin Biotech resident client entrinsic bioscience (EBS), a company pioneering a next-generation protein modulation technology, announced that it has been granted U.S. Patent No. (USPN) 10,758,507 (‘507 patent) for novel therapeutic formulations in the treatment of a range of respiratory diseases with significant unmet medical needs. EBS is […]
Concept Companies Unveils New Office for Lacerta Therapeutics in Alachua’s Copeland Park
Gainesville-based developer Concept Companies has completed construction on a new 12,950-square-foot office and lab building in Copeland Park for UF startup and UF Innovate | Sid Martin Biotech alum Lacerta Therapeutics, a clinical-stage gene therapy company. With its official move-in date on July 27, 2020, Lacerta Therapeutics is the newest tenant in Alachua’s Copeland Park. […]
AGTC Joins the My Retina Tracker Program as a New Scientific Collaborator
UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation Fighting Blindness, announced that AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, will join the My Retina Tracker Program as a new scientific collaborator […]